These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 30551433)
1. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2. Li Q; Song W; Wang J Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. Zhang Y; Liu Y; Xu X J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500 [TBL] [Abstract][Full Text] [Related]
3. Silencing LINC00987 ameliorates adriamycin resistance of acute myeloid leukemia via miR-4458/HMGA2 axis. Liu Y; Zhu XY; Liao LL; Zhang ZH; Huang TS; Zhang L; Jiang XW; Ma Y Biol Direct; 2024 Jun; 19(1):49. PubMed ID: 38910243 [TBL] [Abstract][Full Text] [Related]
4. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p. Cao J; Han X; Qi X; Jin X; Li X Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349 [TBL] [Abstract][Full Text] [Related]
5. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p. Sun H; Sun Y; Chen Q; Xu Z Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis. Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095 [TBL] [Abstract][Full Text] [Related]
7. TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2. Xu C; Guo Y; Liu H; Chen G; Yan Y; Liu T Cell Biosci; 2018; 8():61. PubMed ID: 30519392 [TBL] [Abstract][Full Text] [Related]
8. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis. Zhang X; Yang L; Xu G Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119 [TBL] [Abstract][Full Text] [Related]
9. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway. Kang Y; Zhang S; Cao W; Wan D; Sun L Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817 [TBL] [Abstract][Full Text] [Related]
11. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382. Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia. Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398 [TBL] [Abstract][Full Text] [Related]
13. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a. Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533 [TBL] [Abstract][Full Text] [Related]
14. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis. Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757 [TBL] [Abstract][Full Text] [Related]
15. Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia. Liu B; Ma X; Liu Q; Xiao Y; Pan S; Jia L Cell Death Dis; 2018 Jun; 9(6):688. PubMed ID: 29880818 [TBL] [Abstract][Full Text] [Related]
16. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia. Qin J; Bao H; Li H Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403 [TBL] [Abstract][Full Text] [Related]
17. Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin. Liu H; Liu M; Zhang J; Liang Y Mol Med Rep; 2020 Oct; 22(4):2810-2816. PubMed ID: 32945422 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens. Luo W; Yu H; Zou X; Ni X; Wei J Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1. Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]